Ординатура / Офтальмология / Английские материалы / Ocular Traumatology_Kuhn_2008

DO:

•try to achieve a complete PVD in each case, consistent with safety

•consider early removal of a vitreous hemorrhage, irrespective of whether open or closed globe trauma was the cause

•explain to the patient that visual symptoms caused by contusion retino(maculo)pathy may spontaneously improve with time, but no specific treatment can be offered

•trauma-related retinal breaks should be treated with laser, especially if they are symptomatic

•the primary goal of vitrectomy for most retinal detachments is the elimination of traction; in a hemorrhagic detachment, the blood needs to be evacuated

•don’t compromise in your surgical goals because of visibility problems; most of these problems can be eliminated or at least improved intraoperatively if proper attention is given to them

•if silicone oil use in a traumatized eye is contemplated, the answer is generally “yes”

DON’T:

•accept the preoperative finding that a PVD is present in the injured eye; even intraoperatively, TA use is recommended to confirm this

•assume that retinal detachment is unlikely to occur in an eye with contusion-re- lated vitreous hemorrhage

•forgo treatment of a macular hole just because additional macular pathologies are present; the visual acuity can nevertheless improve

•assume that just because all went well intraoperatively in an eye undergoing surgery with trauma-related PVR, all will go well postoperatively; the recurrence rate is high

•insist on lens preservation if this might compromise the success of retinal surgery

•use PFCL to open a closed funnel: viscoelastic is the right tool

•remove the silicone oil too early from an injured eye

•use prophylactic cryopexy in eyes with scleral wound, especially if this were to be done “blindly”

328 Ferenc Kuhn

Summary

The visual outcome of the injured eye is primarily determined by the condition of the macula. Careful evaluation of the posterior segment is

mandatory after a serious injury, and timely treatment should be considered if a treatable pathology is identified.

References

[1]Abrams G, Azen S, McCuen B, Flynn H, Lai M, Ryan S (1997) Vitrectomy with silicone oil or perfluorocarbon gas in eyes with severe PVR. Results of additional and long-term follow-up. Arch Ophthalmol 115: 335−344

[2]Alameri A, Baker NS (2005) Successful use of recombinant activated factor VII in the treatment of vitreous haemorrhage: a report of seven cases. Blood Coagul Fibrinolysis 16: 573−578

[3]Allinson RW (2002) Adjuvant 5-FU and heparin prevent PVR. Ophthalmology 109: 829−830; author reply 830

[4]Aralikatti AK, Haridas AS, Smith JM (2006) Delayed Nd:YAG laser membranotomy for traumatic premacular hemorrhage. Arch Ophthalmol 124: 1503

[5]Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, Aylward GW (2001) Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology 108: 1179−1183

[6]Asaria RH, Zaman A, Sullivan PM (1999) Retinitis sclopetaria associated with airbag inflation. Br J Ophthalmol 83: 1094−1095

[7]Bartz-Schmidt KU, Kirchhof B, Heimann K (1996) Risk factors for retinal redetachment by proliferative vitreoretinopathy after episcleral surgery for pseudophakic retinal detachment. Klin Monatsbl Augenheilkd 208: 82−86 [in German]

[8]Burk SE, Da Mata AP, Snyder ME, Rosa RH Jr, Foster RE (2000) Indocyanine greenassisted peeling of the retinal internal limiting membrane. Ophthalmology 107: 2010−2014

[9]Campochiaro PA, Gaskin HC, Vinores SA (1987) Retinal cryopexy stimulates traction retinal detachment in the presence of an ocular wound. Arch Ophthalmol 1567−1570

[10]Capeans C, Lorenzo J, Santos L, Suarez A, Copena MJ, Blanco MJ, Sanchez-Salorio M (1998) Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy. Graefe’s Arch Clin Exp Ophthalmol 236: 481−485

[11]Cardillo JA, Stout JT, LaBree L, Azen SP, Omphroy L, Cui JZ, Kimura H, Hinton DR, Ryan SJ (1997) Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology 104: 1166−1173

[12]Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH, Bunce C (2004) A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology 111: 2240−2245

[13]Chaudhry N, Mieler W, Han D, Alfaro V, Liggett P (1999) Preoperative use of tissue plasminogen activator for large submacular hemorrhage. Ophthalmic Surg Lasers

30:176−180

[14]Cibis P, Yamashita T, Rodriguez F (1959) Clinical aspects of ocular siderosis and hemosiderosis. Arch Ophthalmol 62: 46−53

[15]Clarkson JG, Flynn HW, Daily MJ (1980) Vitrectomy in Terson’s syndrome. Am J Ophthalmol 90: 540−552

[16]Cleary PE, Ryan SJ (1979) Method of production and natural history of experimental posterior penetrating eye injury in the rhesus monkey. Am J Ophthalmol 88: 212−220

[17]Cleary PE, Ryan SJ (1981) Vitrectomy in penetrating eye injury. Arch Ophthalmol

99:287−292

[18]Coleman D (1982) Early vitrectomy in the management of the severely traumatized eye. Am J Ophthalmol 93: 543−551

[19]Conway MD, Peyman GA, Recasens M (1999) Intravitreal tPA and SF6 promote clearing of premacular subhyaloid hemorrhages in shaken and battered baby syndrome. Ophthalmic Surg Lasers 30: 435−441

[20]Cowley M, Conway BP, Campochiaro PA, Kaiser D, Gaskin H (1989) Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol 107: 1147−1151

[21]Cox MS, Schepens CL, Freeman HM (1966) Retinal detachment due to ocular contusion. Arch Ophthalmol 76: 678−685

[22]Coyler M, Weber E, Weichel E, Dick J, Bower K, Ward T, Haller J (in press) Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi and Enduring Freedom. Ophthalmology

[23]De Pool ME, Campbell JP, Broome SO, Guyton DL (2005) The dragged-fovea diplopia syndrome: clinical characteristics, diagnosis, and treatment. Ophthalmology

112:1455−1462

[24]Dellaporta AN (1994) Evacuation of subretinal hemorrhage. Int Ophthalmol 18: 25−31

[25]Desai UR (1995) Spontaneous vitreous base avulsion in a patient with neurofibromatosis. Indian J Ophthalmol 43: 33

[26]Desatnik H, Treister G, Moisseiev J (1999) Spontaneous separation of an idiopathic macular pucker in a young girl. Am J Ophthalmol 127: 729−731

330 Ferenc Kuhn

[27]Dong X, Chen N, Xie L, Wang S (2006) Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid. Retina 26: 210−213

[28]Dumas C, Bonnet M (1996) Choroidal detachment associated with rhegmatogenous retinal detachment: a risk factor for postoperative PVR?. J Fr Ophtalmol 19: 455−463

[29]Durukan AH, Kerimoglu H, Erdurman C, Demirel A, Karagul S (2006) Long-term results of Nd:YAG laser treatment for premacular subhyaloid haemorrhage owing to Valsalva retinopathy. Eye

[30]Ehrenberg M, Tresher RJ, Machemer R (1984) Vitreous hemorrhage nontoxic to retina as a stimulator of glial and fibrous proliferation. Am J Ophthalmol 97: 611−626

[31]Engelbrecht N, Freeman J, Sternberg PJ, Aaberg TS, Aaberg TJ, Martin D, Sippy B (2002) Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 89−94

[32]Er H, Turkoz Y, Mizrak B, Parlakpinar H (2006) Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. Ophthalmologica 220: 17−22

[33]Ersanli D, Sonmez M, Unal M, Gulecek O (2006) Management of retinal detachment due to closed globe injury by pars plana vitrectomy with and without scleral buckling. Retina 26: 32−36

[34]Fraser EA, Cheema RA, Roberts MA (2003) Triamcinolone acetonide-assisted peeling of retinal internal limiting membrane for macular surgery. Retina 23: 883−884

[35]Girard P, Mimoun G, Karpouzas I, Montefiore G (1994) Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 14: 417−424

[36]Glatt H, Machemer R (1982) Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 94: 762−773

[37]Guigon-Souquet B, Salaun N, Macarez R, Bazin S, De La Marnierre E, Mazdou M (2004) Subhyaloid hemorrhage following a Valsalva maneuver. J Fr Ophtalmol 27: 1159−1162 [in French]

[38]Halberstadt M, Domig D, Kodjikian L, Koerner F, Garweg JG (2006) PVR recurrence and the timing of silicon oil removal. Klin Monatsbl Augenheilkd 223: 361−366

[39]Hermsen V (1984) Vitrectomy in severe ocular trauma. Ophthalmologica 189: 86−92

[40]Hesse L, Bodanowitz S, Kroll P (1996) Retinal necrosis after blunt bulbus trauma. Klin Monatsbl Augenheilkd 209: 150−152 [in German]

[41]Horio N, Horiguchi M (2004) Retinal blood flow analysis using intraoperative video fluorescein angiography combined with optical fiber-free intravitreal surgery system. Am J Ophthalmol 138: 1082−1083

[42]Isernhagen RD, Smiddy WE, Michels RG (1988) Vitrectomy for nondiabetic vitreous hemorrhage. Not associated with vascular disease. Retina 8: 81−87

[43]Ismail R, Tanner V, Williamson TH (2002) Optical coherence tomography imaging of severe commotio retinae and associated macular hole. Br J Ophthalmol 86: 473−474

[44]Kennedy C, Parker C, McAllister I (1997) Retinal detachment caused by retinal dialysis. Aust N Z J Ophthalmol 251: 25−30

[45]Kishi S, Hagimura N, Shimizu K (1996) The role of the premacular liquefied pocket and premacular vitreous complex in idiopathic macular hole development. Am J Ophthalmol 122: 622−628

[46]Koh HJ, Kim SH, Lee SC, Kwon OW (2000) Treatment of subhyaloid haemorrhage with intravitreal tissue plasminogen activator and C3F8 gas injection. Br J Ophthalmol 84: 1329−1330

[47]Kuhn F, Kiss G, Mester V, Szijarto Z, Kovacs B (2004) Vitrectomy with internal limiting membrane removal for clinically significant macular edema. Graefe’s Arch Clin Exper Ophthal 242: 402−408

[48]Kuhn F, Mester V, Berta A (1998) The Tano diamond dusted membrane scraper: indications and contraindications. Acta Ophthalmol 76: 754−756

[49]Kuhn F, Mester V, Morris R (2004) A proactive treatment approach for eyes with perforating injury. Klin Monatsbl Augenheilk 221: 622−628

[50]Kuhn F, Morris R, Mester V, Witherspoon C (1998) Terson’s syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage. Ophthalmology 105: 472−477

[51]Kuhn F, Morris R, Mester V, Witherspoon C (2000) Internal limiting membrane removal for traumatic macular holes. Ophthalmol Surg Laser 31: 308−315

[52]Kuppermann BD, Thomas EL, de Smet MD, Grillone LR (2005) Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 140: 573−584

[53]Kuriyama S, Ohuchi T, Yoshimura N, Honda Y, Hiraoka M, Abe M (1990) Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits. Graefe’s Arch Clin Exp Ophthalmol 228: 552−555

[54]Lemor M, Yeo JH, Glaser BM (1986) Oral colchicine for the treatment of experimental traction retinal detachment. Arch Ophthalmol 104: 1226−1229

[55]Li K, Wong D, Hiscott P, Stanga P, Groenewald C, McGalliard J (2003) Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol 87: 216−219

[56]Liggett P, Gauderman W, Moreira C, Barlow W, Green R, Ryan S (1990) Pars plana vitrectomy for acute retinal detachment in penetrating ocular injuries. Arch Ophthalmol 108: 1724−1728

[57]Lincoff H, Madjarov B, Lincoff N, Movshovich A, Saxena S, Coleman DJ, Schubert H, Rosberger D, McCormick S (2003) Pathogenesis of the vitreous cloud emanating from subretinal hemorrhage. Arch Ophthalmol 121: 91−96

332 Ferenc Kuhn

[58]Machemer R, Sugita G, Tano Y (1979) Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 77: 171−180

[59]Majid MA, Hussain HM, Haynes RJ, Dick AD (2006) Buckle, no cryo: scleral buckle with no cryotherapy for retinal detachment secondary to commotio retinae. Br J Ophthalmol 90: 1550−1551

[60]Matsumoto C, Arimura E, Okuyama S, Takada S, Hashimoto S, Shimomura Y (2003) Quantification of metamorphopsia in patients with epiretinal membranes. Invest Ophthalmol Vis Sci 44: 4012−4016

[61]Miller-Meeks MJ, Bennett SR, Keech RV, Blodi CF (1990) Myopia induced by vitreous hemorrhage. Am J Ophthalmol 109: 199−203

[62]Morris R, Kuhn F (1998) Surgical treatment of macular surface disorders. Highlights of Ophthalmology International, Panama City, pp 58−64

[63]Morris R, Kuhn F, Mester V (2000) Prophylactic scleral buckle for prevention of retinal detachment following vitrectomy for macular hole. Br J Ophthalmol 84: 673

[64]Morris R, Kuhn F, Witherspoon C (1993) Hemorrhagic macular cysts. Ophthalmology 100: 1

[65]Morris R, Kuhn F, Witherspoon C (1994) Retinal folds and hemorrhagic macular cysts in Terson’s syndrome. Ophthalmology 101: 1

[66]Moshfeghi AA, Harrison SA, Reinstein DZ, Ferrone PJ (2006) Valsalva-like retinopathy following hyperopic laser in situ keratomileusis. Ophthalmic Surg Lasers Imaging 37: 486−488

[67]Munir WM, Pulido JS, Sharma MC, Buerk BM (2005) Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy. Can J Ophthalmol 40: 598−604

[68]O’Hanley GP, Canny CL (1985) Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomy. Ophthalmology 92: 507−511

[69]Park SW, Seo MS (2004) Subhyaloid hemorrhage treated with SF6 gas injection. Ophthalmic Surg Lasers Imaging 35: 335−337

[70]Puustjarvi TJ, Terasvirta ME (2001) Retinal fixation of traumatic retinal detachment with metallic tacks: a case report with 10 years’ follow-up. Retina 21: 54−56

[71]Richards R, West C, Meisels A (1968) Chorioretinitis sclopetaria. Trans Am Ophthalmol Soc 66: 214−232

[72]Sandner D, Herbrig E, Engelmann K (2007) High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefe’s Arch Clin Exp Ophthalmol

[73]Schmidt JG (1987) Intravitreal cupriferous foreign bodies: electroretinograms and inflammatory responses. Doc Ophthalmol 67: 253−261

[74]Sebag J (2005) Molecular biology of pharmacologic vitreolysis. Trans Am Ophthalmol Soc 103: 473−494

[75]Shinohara K, Tanaka M, Sakuma T, Kobayashi Y (2003) Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging 34: 299−305

[76]Sipperley JO, Quigley HA, Gass DM (1978) Traumatic retinopathy in primates. The explanation of commotio retinae. Arch Ophthalmol 96: 2267−2273

[77]Skorpik C, Menapace R, Gnad HD, Paroussis P (1989) Silicone oil implantation in penetrating injuries complicated by PVR. Results from 1982 to 1986. Retina 9: 8−14

[78]Spraul CW, Grossniklaus HE (1997) Vitreous hemorrhage. Surv Ophthalmol 42: 3−39

[79]Sternberg P Jr, Han DP, Yeo JH, Barr CC, Lewis H, Williams GA, Mieler WF (1988) Photocoagulation to prevent retinal detachment in acute retinal necrosis. Ophthalmology 95: 1389−1393

[80]Stone TW, Siddiqui N, Arroyo JG, McCuen BW 2nd, Postel EA (2000) Primary scleral buckling in open-globe injury involving the posterior segment. Ophthalmology 107: 1923−1926

[81]Tanaka M, Qui H (2000) Pharmacological vitrectomy. Semin Ophthalmol 15: 51−61

[82]Tognetto D, Minutola D, Sanguinetti G, Ravalico G (2005) Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: a pilot study. Ophthalmology 112: 1574

[83]Trese MT (2000) Enzymatic vitreous surgery. Semin Ophthalmol 15: 116−121

[84]Ullern M, Roman S, Dhalluin JF, Lozato P, Grillon S, Bellefqih S, Cambourieu C, Baudouin C (2002) Contribution of intravitreal infracyanine green to macular hole and epimacular membrane surgery: preliminary study. J Fr Ophtalmol 25: 915−920 [in French]

[85]van Bockxmeer FM, Martin CE, Thompson DE, Constable IJ (1985) Taxol for the treatment of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26: 1140−1147

[86]Wallace R, McNamara J, Brown G, Benson W, Belmont J, Goldberg R, Federman J (1993) The use of perfluorophenanthrene in the removal of intravitreal lens fragments. Am J Ophthalmol 116: 196−200

[87]Weidenthal D, Schepens C (1966) Peripheral fundus changes associated with ocular contusion. Am J Ophthalmol 62: 465

[88]Wickham L, Xing W, Bunce C, Sullivan P (2006) Outcomes of surgery for posterior segment intraocular foreign bodies-a retrospective review of 17 years of clinical experience. Graefe’s Arch Clin Exp Ophthalmol

[89]Wiedemann P, Lemmen K, Schmiedl R, Heimann K (1987) Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol 104: 10−14

334 Ferenc Kuhn

[90]Williams RG, Chang S, Comaratta MR, Simoni G (1996) Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy? Graefe’s Arch Clin Exp Ophthalmol 234: 496−503

[91]Wolf S, Schon V, Meier P, Wiedemann P (2003) Silicone oil-RMN3 mixture (“heavy silicone oil”) as internal tamponade for complicated retinal detachment. Retina 23: 335−342

[92]Yamada H, Sakai A, Yamada E, Nishimura T, Matsumura M (2002) Spontaneous closure of traumatic macular hole. Am J Ophthalmol 134: 340−347

[93]Yanoff M (1975) Pathology of cataract. In: Bellows JG (eds) Cataract and abnormalities of the lens. Grune and Stratton, New York, pp 179

[94]Morris R et al. (2006) Prophylactic silicone oil placement for retinal detachments with grades A and B PVR. Association for Research and Vision in Ophthalmology, Fort Lauderdale